Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer
Background/Aims The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating meta-static pancreatic cancer (MPC). We aimed to evaluate the therapeutic outcomes and prognostic role of treatment-related peripheral neuropathy in patients with MPC treated with nab-P/Gem in c...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Gastroenterology Council for Gut and Liver
2018-11-01
|
| Serija: | Gut and Liver |
| Teme: | |
| Online pristup: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl18220 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|